Literature DB >> 8044798

Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization.

G B Baretton1, C Valina, T Vogt, K Schneiderbanger, J Diebold, U Löhrs.   

Abstract

To gain a better understanding of chromosomal aberrations in direct correlation with histology, we studied tumor material from 35 patients (36 regions) with primary prostate carcinoma by nonisotopic in situ hybridization. Nine biotinylated DNA probes were used on serial paraffin sections (centromer-specific probes for X, Y, 1, 7, 8, 10, 17, and 18, and a telomer-specific probe for 1p; ONCOR). Of the 324 hybridized sections, 94% were suitable for evaluation. In 34 of the 35 cases (35 of 36 regions) 1-8 chromosomal aberrations were detected. Chromosome X showed supernumerary centromer copies in 44% of cases. The probes for chromosomes 1, 1p, 10, and 18 demonstrated deletions in 25, 23, 40 and 58% of cases, respectively. Gains as well as deletions were present for Y, 7, 8, and 17 in 31, 25, 36, and 58% of cases, respectively. In 27% of cases discordant copy numbers of the centromer- and the telomer-specific probes for chromosome 1 were observed. No aberration which might be specific for prostate cancer could be established. The rate of aneusomy increased significantly with histological grade. Intratumoral heterogeneity of chromosomal aberrations was revealed in one case. Due to the higher sensitivity of nonisotopic in situ hybridization, aneusomic cases outnumbered cases with cytometrically determined DNA aneuploidy. In view of published results of metaphase preparations, the high frequency of aneusomy and some of the chromosomal aberrations detected by nonisotopic in situ hybridization were unexpected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8044798

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Numerical aberrations of chromosomes 16, 17, and 18 in hepatocellular carcinoma: a FISH and FCM analysis of 20 cases.

Authors:  A Kato; K Kubo; F Kurokawa; K Okita; A Oga; T Murakami
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

2.  The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation--a clinico-pathological study.

Authors:  Iris Bittmann; Adriana Bottino; Gustavo Bruno Baretton; Alexander Ludwig Gerbes; Reinhart Zachoval; Horst Günter Rau; Udo Löhrs
Journal:  Virchows Arch       Date:  2003-07-23       Impact factor: 4.064

3.  Immunomagnetic separation can enrich fixed solid tumors for epithelial cells.

Authors:  M L Yaremko; P R Kelemen; C Kutza; D Barker; C A Westbrook
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

4.  Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage.

Authors:  A J Russell; J Sibbald; H Haak; W N Keith; A M McNicol
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

5.  Y-chromosome loss is frequent in male renal tumors.

Authors:  Franziska Büscheck; Christoph Fraune; Seyedehmina Garmestani; Ronald Simon; Martina Kluth; Claudia Hube-Magg; Kathrin Ketterer; Christian Eichelberg; Doris Höflmayer; Frank Jacobsen; Corinna Wittmer; Waldemar Wilczak; Guido Sauter; Margit Fisch; Till Eichenauer; Michael Rink
Journal:  Ann Transl Med       Date:  2021-02

6.  Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24.

Authors:  Galina I Botchkina; Edison S Zuniga; Rebecca H Rowehl; Rosa Park; Rahuldev Bhalla; Agnieszka B Bialkowska; Francis Johnson; Lorne M Golub; Yu Zhang; Iwao Ojima; Kenneth R Shroyer
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.